Senior Investigator/National Institutes of Health
Internal Medicine
Dr. John F. Tisdale, MD
|
|
Give Review
John Tisdale practices Internal Medicine. He researched medicine at Medical University of South Carolina College of Medicine. He received awards:"Elected Member". John Tisdale is a published MD. He has 99 publications published. The most current publication "Molecular and serological examination of the relationship of human herpesvirus 8 to multiple myeloma: orf 26 sequences in bone marrow stroma are not restricted to myel..." Dr. John F. Tisdale accepts Medicare.
Publications
- SENP1 but not fetal hemoglobin differentiates chronic mountain sickness from healthy Andean highlanders.
- β-globin-expressing definitive erythroid progenitor cells generated from embryonic and induced pluripotent stem cell-derived sacs.
- Whole-body imaging of the immune system reveals discordance in CD4+ lymphoid tissue recovery after transplantation in rhesus macaques.
- Kinetics of lentiviral vector transduction in human CD34(+) cells.
- Public titles of clinical trials should have ethics review.
- Hematopoietic Stem Cell Transplantation for Patients with Sickle Cell Disease: Progress and Future Directions.
- Angioedema in patients treated with sirolimus and ACE inhibitor post hematopoietic SCT.
- Wild type macrophages reverse disease in heme oxygenase-1 deficient mice.
- Successful Fertility Restoration After Allogeneic Hematopoietic Stem Cell Transplantation.
- Acquired haemophilia A after stem cell transplant for sickle cell disease: treatment with recombinant porcine factor VIII (OBI-1) and tolerance induction with rituxima...
- Evaluation of engraftment and immunological tolerance after reduced intensity conditioning in a rhesus hematopoietic stem cell gene therapy model.
- TRIM5α variations influence transduction efficiency with lentiviral vectors in both human and rhesus CD34(+) cells in vitro and in vivo.
- No Impact of Lentiviral Transduction on Hematopoietic Stem/Progenitor Cell Telomere Length or Gene Expression in the Rhesus Macaque Model.
- Efficient transduction of human hematopoietic repopulating cells with a chimeric HIV1-based vector including SIV capsid.
- Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy.
- Sirolimus and post transplant Cy synergistically maintain mixed chimerism in a mismatched murine model.
- MASL1 induces erythroid differentiation in human erythropoietin-dependent CD34+ cells through the Raf/MEK/ERK pathway.
- HCT for nonmalignant disorders.
- Peripheral blood stem cell transplants do not result in endometrial stromal engraftment.
- High-efficiency Transduction of Rhesus Hematopoietic Repopulating Cells by a Modified HIV1-based Lentiviral Vector.
- Infusion of hemolyzed red blood cells within peripheral blood stem cell grafts in patients with and without sickle cell disease.
- Allogeneic hematopoietic stem cell transplant for sickle cell disease: the time is now.
- Accelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34(+) cells mobilized by&A...
- Prostaglandin e2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models.
- Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector.
- 5% dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSO.
- The assessment of human erythroid output in NOD/SCID mice reconstituted with human hematopoietic stem cells.
- Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?
- Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.
- Development of a human immunodeficiency virus type 1-based lentiviral vector that allows efficient transduction of both human and rhesus blood cells.
- Incidence of second cancers after allogeneic hematopoietic stem cell transplantation using reduced-dose radiation.
- Transient in vivo beta-globin production after lentiviral gene transfer to hematopoietic stem cells in the nonhuman primate.
- Busulfan produces efficient human cell engraftment in NOD/LtSz-Scid IL2Rgamma(null) mice.
- Long-term vector integration site analysis following retroviral mediated gene transfer to hematopoietic stem cells for the treatment of HIV infection.
- Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population.
- STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells.
- Transfusion-associated babesiosis with an atypical time course after nonmyeloablative transplantation for sickle cell disease.
- Sirolimus associated pneumonitis after nonmyeloablative peripheral blood stem cell transplant for sickle cell disease.
- HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques.
- Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences.
- A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference.
- Low-dose radiation plus rapamycin promotes long-term bone marrow chimerism.
- Side population cells derived from adult human liver generate hepatocyte-like cells in vitro.
- Cloning and functional analysis of the rhesus macaque ABCG2 gene. Forced expression confers an SP phenotype among hematopoietic stem cell progeny in vivo.
- Gene therapy for the hemoglobin disorders.
- The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
- Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leuk...
- Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blo...
- Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus.
- Retrovirally transduced muscle-derived cells contribute to hematopoiesis at very low levels in the nonhuman primate model.
- Efficient characterization of retro-, lenti-, and foamyvector-transduced cell populations by high-accuracy insertion site sequencing.
- Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): follow-up of a randomized trial.
- Polyclonal long-term repopulating stem cell clones in a primate model.
- Gene therapy-based treatment for HIV-positive patients with malignancies.
- High-dose cyclophosphamide for treatment of aplastic anemia.
- Plasticity and hematopoiesis: Circe's transforming potion?
- Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait.
- Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patient...
- Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia.
- Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34(+) Cells Correlates With In Vivo Vector Copy Number.
- Addition of Rapamycin to Anti-CD3 Antibody Improves Long-Term Glycaemia Control in Diabetic NOD Mice.
- A National Institute for Occupational Safety and Health Alert sent to hospitals and the intentions of hospital decision makers to advocate for latex allergy control me...
- Over a thousand ambulatory hernia repairs in a primary care setting.
- Late generalized tuberculosis: unusual features of an often overlooked disease.
- Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts.
- Growth inhibition of chronic myelogenous leukemia cells by ODN-1, an aptameric inhibitor of p210bcr-abl tyrosine kinase activity.
- Fever, weight loss, and pancytopenia in an elderly man.
- Cardiomyogenesis in the adult human heart.
- Toward gene therapy for disorders of globin synthesis.
- American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells.
- Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis.
- Proteomic signature of myeloproliferation and neutrophilia: analysis of serum and plasma from healthy subjects given granulocyte colony-stimulating factor.
- Engraftment of gene-marked hematopoietic progenitors in myeloma patients after transplant of autologous long-term marrow cultures.
- T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect.
- In vivo persistence of retrovirally transduced murine long-term repopulating cells is not limited by expression of foreign gene products in the fully or minimally myel...
- Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic ane...
- Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
- Transduction of hematopoietic stem cells in humans and in nonhuman primates.
- Hepatitis-associated aplastic anemia.
- Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tum...
- Therapeutic options for patients with severe beta-thalassemia: the need for globin gene therapy.
- Cerebrovascular disease associated with sickle cell pulmonary hypertension.
- Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation.
- A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers.
- Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.
- Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating.
- Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
- How much insulin is enough? A quantitative assessment of the transdifferentiaton potential of liver.
- Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability.
- Murine bone marrow expressing the neomycin resistance gene has no competitive disadvantage assessed in vivo.
- Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning.
- No discrepancy between in vivo gene marking efficiency assessed in peripheral blood populations compared with bone marrow progenitors or CD34+ cells.
- Molecular and serological examination of the relationship of human herpesvirus 8 to multiple myeloma: orf 26 sequences in bone marrow stroma are not restricted to myel...
- Severe thrombocytopenia in patients treated with suramin: evidence for an immune mechanism in one.
- Right leg swelling and weight loss in an elderly man.
- A subtle radiographic finding with fatal implications.
- Agranulocytosis in a hyperthyroid patient.
- Ehrlichiosis.
Schools
Medical University of South Carolina
Vanderbilt University Hospital
Nhlbi National Institute Health
Doctors Specialties
- Hematology
- Internal Medicine
Accepted Insurances
Awards
- Elected Member
Education
-
National Institutes of Health Clinical Center -
Vanderbilt University -
Medical University of South Carolina College of Medicine
Drug Facts
| NPI NUMBER | 1649414525 | |
| NPPES Provider LastName | TISDALE | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 86503 | |
| NPPES Provider State | AZ | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 240.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649414525 |
| Last Name Of The Provider | TISDALE |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Giovanna Tosato, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gregory K. Frykman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wyatt S. Smith, DO |
|
|
Dr. Colleen A. Dorrance, MD |
|
|
Dr. John E. Janik, MD |
|
|
Dr. Daniel Rosenblum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shakuntala M. Malik, MD |
|
|
Dr. Corey A. Carter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James X. Xu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anitha P. Chetty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis A. Cullen, MD
This Doctor is OpenDoctor Recommended.
|